Responsible botanical wellness begins with verified sourcing, independent testing, and clear communication – especially when working with rare plant compounds such as EBC-46.
“A core principle of our work is scientific transparency,” says Dr. Annmarie Kyle, M.D., medical advisor to Blushwood Health. “Responsible botanical wellness starts with verified sourcing, independent testing, and clear communication – allowing consumers to make informed choices based on objective data rather than marketing claims.”
Blushwood Health offers both capsule and tincture formats designed to integrate seamlessly into daily wellness routines. The company serves customers in more than 40 countries and maintains high satisfaction ratings across independent review platforms, including Trustpilot and Reviews.io.
EBC-46 has been documented in peer-reviewed scientific literature and explored in preclinical research settings by institutions such as the QIMR Berghofer Medical Research Institute. Ongoing academic interest has highlighted the compound’s distinctive botanical origin and biochemical characteristics, contributing to broader scientific understanding of plant-derived compounds.
Blushwood Health’s mission is to set a higher standard for botanical wellness – emphasizing independent verification, medical review, and transparency at every stage of production in response to growing global demand for evidence-guided natural health solutions.
For media inquiries, data assets, and brand information, visit www.blushwood.health or contact [email protected].
Media Contact
Jonas Lundgren, Blushwood Health, 46 730843401, [email protected], https://blushwood.health
SOURCE Blushwood Health
